Director Declaration
Updated : 11:54
Convatec Director Declaration
Reading, United Kingdom (7 July 2022)
Convatec Group Plc ("Convatec" or "the Company") announces that Sharon O'Keefe, a non-executive director of the Company, has been appointed as a non-executive director of Apollo Endosurgery Inc. (Nasdaq: APEN), with effect from 6 July 2022.
This announcement is made in accordance with Listing Rule 9.6.14R.
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, Convatec +44 (0)782 644 7807
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 250 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over $2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http://www.convatecgroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.